Inexpensive method detects ALK rearrangement in lung cancer patients
Tuesday, August 2, 2011 - 16:30
in Health & Medicine
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to new research.